95 related articles for article (PubMed ID: 3513472)
1. Surgical biopsy of non-palpable mammary lesions. Technique and results.
Arnesson LG; Fagerberg G; Gröntoft O; Lundström B
Acta Chir Scand; 1986 Feb; 152():97-101. PubMed ID: 3513472
[TBL] [Abstract][Full Text] [Related]
2. [Non palpable lesions of the breast: the Mammotome-biopsy in the preoperative management of breast cancer].
Ceccarelli G; Casciola L; Battistini I; Stefanoni M; Spaziani A; Conti D; Di Zitti L; Valeri R; Bartoli A; Bellochi R; Rambotti M; Pisanelli MC
G Chir; 2005 May; 26(5):187-93. PubMed ID: 16184700
[TBL] [Abstract][Full Text] [Related]
3. [Surgical treatment of breast lesions: preliminary results of the screening program of the Ariana area].
Chelli D; Dimassi K; Salem A; Driss M; Zaanouni E; Zouaoui B; Sfar E; Ben Aissa R; Chelli H; Chennoufi BM; Boussen H
Tunis Med; 2009 Jul; 87(7):475-9. PubMed ID: 20063683
[TBL] [Abstract][Full Text] [Related]
4. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle].
Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C
Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438
[TBL] [Abstract][Full Text] [Related]
5. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Port ER; Park A; Borgen PI; Morris E; Montgomery LL
Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
[TBL] [Abstract][Full Text] [Related]
6. Excisional breast biopsy: when, why and how?
Bellantone R; Rossi S; Lombardi CP; Cinini C; Minelli S; Crucitti F
Int Surg; 1995; 80(1):75-8. PubMed ID: 7657498
[TBL] [Abstract][Full Text] [Related]
7. [Stereotaxic excisional biopsy of non-palpable breast lesions by the ABBI(Advanced Breast Biopsy Instrumentation) technique. Advantages. Disadvantages. Indications. Apropos of 67 cases].
Atallah N; Karam R; Younane T; Aftimos G
J Med Liban; 2000; 48(2):70-6. PubMed ID: 11028153
[TBL] [Abstract][Full Text] [Related]
8. Experience with fine-wire localization breast biopsies for nonpalpable breast lesions detected mammographically.
Luoma AA; Scudamore CH; Longley JD
Can J Surg; 1986 Sep; 29(5):315-8. PubMed ID: 3790211
[TBL] [Abstract][Full Text] [Related]
9. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004).
Manfrin E; Mariotto R; Remo A; Reghellin D; Falsirollo F; Dalfior D; Bricolo P; Piazzola E; Bonetti F
Cancer; 2009 Feb; 115(3):499-507. PubMed ID: 19117040
[TBL] [Abstract][Full Text] [Related]
10. The abnormal mammogram in women with clinically normal breasts.
Sterns EE
Can J Surg; 1995 Apr; 38(2):168-72. PubMed ID: 7728672
[TBL] [Abstract][Full Text] [Related]
11. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
Kuhl CK; Schrading S; Weigel S; Nüssle-Kügele K; Sittek H; Arand B; Morakkabati N; Leutner C; Tombach B; Nordhoff D; Perlet C; Rieber A; Heindel W; Brambs HJ; Schild H
Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631
[TBL] [Abstract][Full Text] [Related]
12. [The use of stereotaxic cytology in the diagnosis of nonpalpable breast lesions. Our experience].
Cipolla C; Amato C; Grillo A; Graceffa G; Tomasino RM; Nuara RB; Morello V; Latteri MA
Minerva Chir; 1999 Apr; 54(4):239-44. PubMed ID: 10380522
[TBL] [Abstract][Full Text] [Related]
13. [Surgical aspects of breast cancer screening at our hospital].
Márkus B; Bajner A; Csejtei A; Firisz B; Hegedus A; Kocsis E; Kovács B; Pintér G; Tóth C
Magy Seb; 2006 Oct; 59(5):375-82. PubMed ID: 17201346
[TBL] [Abstract][Full Text] [Related]
14. Follow-up recommendations for benign breast biopsies.
Shin S; Schneider HB; Cole FJ; Laronga C
Breast J; 2006; 12(5):413-7. PubMed ID: 16958957
[TBL] [Abstract][Full Text] [Related]
15. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions.
Garg S; Mohan H; Bal A; Attri AK; Kochhar S
Diagn Cytopathol; 2007 Nov; 35(11):681-9. PubMed ID: 17924407
[TBL] [Abstract][Full Text] [Related]
16. Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden.
Tabár L; Gad A; Holmberg L; Ljungquist U
Diagn Imaging Clin Med; 1985; 54(3-4):158-64. PubMed ID: 3896614
[TBL] [Abstract][Full Text] [Related]
17. [Early detection of breast cancer by mass screening using mammography].
Morimoto T; Sasa M; Yamaguchi T; Harada K; Kondo H; Kuroda R
Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():158-63. PubMed ID: 8037479
[TBL] [Abstract][Full Text] [Related]
18. [Radiosurgical labeling of non-palpable mammary lesions].
Aguirre B; Gutiérrez L; Ortega D; Laupheimer S; Taborga M
Rev Med Chil; 1997 Sep; 125(9):1032-5. PubMed ID: 9595794
[TBL] [Abstract][Full Text] [Related]
19. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
Costa MJ; Tadros T; Hilton G; Birdsong G
Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic role of mammography and clinical examination in the framework of a screening program for breast carcinoma in Brescia].
Filippini L; Pinelli D; Bettoni C; Bianchi A; Perna F; Lucini L; Vaiana R; Braga M
Minerva Med; 1996 Nov; 87(11):531-8. PubMed ID: 9045104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
